Found 485 All Conditions trials
A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
We will be using novel qualitative methods for patient engagement (i.e., patient-centered design research methodology) to explore and refine methods of communicating spina bifida-related surgical procedures to patients in a way that they can use to communicate with providers.
The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetaxel alone.
Researchers at Indiana University are currently enrolling participants in a research study to better understand the movement of amputated limbs and how the prosthesis impacts health.
The purpose of the study is to assess safety and tolerability of a Phase I drug, INBRX-101 in patients with alpha-1 antitrypsin deficiency (AATD).
The purpose of this study is to understand how often people with spina bifida experience either urinary (leaking bladder) or fecal incontinence (leaking stool) from day to day, and to investigate how incontinence impacts their daily feelings and activities.
This is a three to four visit study, spanning approximately two to six weeks, in which subjects with asthma and healthy volunteers will undergo screening, baseline characterization, a research bronchoscopy, and a non-invasive challenge test with inhaled GSNO followed by repeated measurements of airway function and inflammation.
This phase II trial studies how well giving radiation therapy together with gemcitabine hydrochloride and cisplatin work in treating patients with locally advanced squamous cell carcinoma of the vulva.
The objective of the registry is to collect information on the natural course of severe chronic neutropenia (SCN) and its response to treatment with the blood-stimulating factor called granulocyte colony stimulating factor or G-CSF (Neupogen).
This research trial studies biomarkers in tumor tissue samples from patients with newly diagnosed neuroblastoma or ganglioneuroblastoma.
